Results 51 to 60 of about 2,911,959 (179)

Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.

PLoS ONE, 2017
Background and aimAntibodies against hepatitis B core antigen (anti-HBc) are found in 14-44% of patients with HIV infection, but it is still unclear whether hepatitis B virus (HBV) vaccination should be recommended for HIV-positive subjects with isolated
Giulia Morsica, Sabrina Bagaglio, Vincenzo Spagnuolo, Antonella Castagna, Clelia Di Serio, Andrea Galli, Liviana Della Torre, Andrea Andolina, Alexander Pramov, Caterina Uberti-Foppa   +9 more
doaj   +1 more source

Booster immunity – diagnosis of chronic hepatitis B viral infection

Journal of Infection in Developing Countries, 2019
Introduction: Diagnosis of chronic hepatitis B virus (HBV) infection particularly its occult form requires monitoring and repeat serological and molecular studies.
Radka T Komitova, Ani K Kevorkyan, Maria V Atanasova, Aneta V Ivanova, Elica Golkocheva-Markova   +4 more
doaj   +1 more source

Home Based Care Services as Strategy to Support Anti-Retroviral Adherence: The Case of Musoma Municipal, Mara region [PDF]

, 2012
A descriptive qualitative study was conducted to assess whether Home Based Care services can be used as a strategy to support Anti-retroviral adherence for People living with HIV/AIDS (PLWHA) in Musoma Municipality, Mara region in March 2012.
Rwezaura, P.K., Rwezaura, Pamela Kokusima   +1 more
core  

The Role of Innate Lymphoid Cells in Autoimmune, Allergic and Infectious Diseases: A Systematic Review

Immunology, EarlyView.
This systematic review establishes disease‐specific dysregulations of human innate lymphoid cells (ILCs), demonstrating that an ILC1/ILC3 imbalance compromises mucosal barriers in inflammatory bowel disease, while activated ILC2s drive allergic airway inflammation.
Luan F. Lückmann, Henrique R. Dal‐Pizzol, Louise M. Lückmann, Davi E. Salini, Bruna C. Hasckel, Mikaeli Minati, Bruno Kluwe‐Schiavon, Tatiana Barichello   +7 more
wiley   +1 more source

Prevalence of Sero-Molecular Markers of Hepatitis C and B Viruses among Patients with β-Thalassemia Major in Northern West Bank, Palestine

Canadian Journal of Infectious Diseases and Medical Microbiology, 2018
Background. HCV and HBV present a great challenge in the management of β-thalassemia patients. Objective. The present study aimed to determine the prevalence of both HBV and HCV in multitransfused-dependent β-thalassemia patients in northern West Bank ...
Kamal Dumaidi, Amer Al-Jawabreh, Fekri Samarah, Maha Rabayaa   +3 more
doaj   +1 more source

Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy

Microorganisms, 2020
Chronic hepatitis B virus (HBV) infection may be reactivated by immunosuppressive drugs in patients with autoimmune inflammatory rheumatic diseases.
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, Paola Begini, Michela Ileen Biondo, Sara Caporuscio, Vincenzo Colonna, Francesca Della Casa, Paola Conigliaro, Cinzia Marrese, Eleonora Celletti, Irene Modesto, Mario Stefano Peragallo, Bruno Laganà, Andrea Picchianti-Diamanti, Roberta Di Rosa, Claudia Ferlito, Simonetta Salemi, Raffaele D’Amelio, Tommaso Stroffolini   +19 more
doaj   +1 more source

Bacteriophage P22 Virus‐Like Particles as Nanoscale Protein Scaffolds for Plant Synthetic Biology

Plant Biotechnology Journal, EarlyView.
ABSTRACT Advancing the utility of plant synthetic biology requires the continued development of protein engineering tools. Self‐assembling protein compartments, such as virus‐like particles (VLPs), provide versatile scaffolds for synthetic biology. However, few plant‐expressed VLPs have demonstrated broad amenability to protein engineering, restricting
Maxim D. Harding, Mark A. Jackson, Edward K. Gilding, David J. Craik, Frank Sainsbury, Nicole Lawrence   +5 more
wiley   +1 more source

International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection [PDF]

BackgroundHepatitis B core antibody (anti-HBc) screening has been implemented in many blood establishments to help prevent transmission of hepatitis B virus (HBV), including from donors with occult HBV infection (OBI).
Sawadogo, Salam, Tsoi, Wai-Chiu, Lewin, Antoine, van de Laar, Thijs, Tsoi, Wai‐Chiu, Perez, Laura Navarro, Irving, William L., Garcia‐Otalora, Michel‐Andres, Fu, Michael, Harvala, Heli, Goto, Naoko, Weber‐Schehl, Marijke, Yilmaz, Soner, Zhiburt, Eugene, on behalf of the Virology subgroup of the ISBT WP-TTID, Saa, Paula, Jones, Ann, Jarvis, Lisa, Weber-Schehl, Marijke, Aidoo, Nana Benyin, Andersson, Monique, Deng, Xuelian, Drews, Steven J., Muylaert, An, Vermeulen, Marion, Niederhauser, Christoph, Styles, Claire, Cloutier, Marc, Juhl, David, Fu, Michael X., Groves, Jamel, Irving, William L, Pajares, Ángel Luis, Faddy, Helen M, O'Brien, Sheila F, Blackmore, Stuart, Van Gaever, Véronique, Chanarsabz, Nahid, Simmonds, Peter, Perez Carrillo, Jose, Brailsford, Su, Candotti, Daniel, Renaud, Christian, Drews, Steven J, Satake, Masahiro, Carrillo, Jose Perez, O'Brien, Sheila F., Adesina, Opeyemi, Lehtisalo, Riikka, Navarro Perez, Laura, Faddy, Helen M., Reynolds, Claire, Benyin Aidoo, Nana, Busch, Michael, Seltsam, Axel, Laperche, Syria, O'Flaherty, Niamh, Chenarsabz, Nahid, Garcia-Otalora, Michel-Andres   +58 more
core   +1 more source

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

Transplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia, Britta L. Hirsch, Irene A. Abela, Karen E. Doucette   +3 more
wiley   +1 more source

The underlying mechanisms for the 'anti-HBc alone' serological profile

, 2020
The serological pattern, ''anti-HBc alone'', characterized by the presence of antibodies against the core antigen of hepatitis B virus (anti-HBc) as the only marker of hepatitis B, is not rare in a diagnostic setting. Depending on the
R A A Pondé, • M O Ferro, • D D P Cardoso   +2 more
core